Related Experiment Videos
Patentees research and development expenditure in Canada
1Humber College of Applied Arts and Technology, Regulatory Affairs Program, Toronto, Ontario, Canada. stephen.li.a@utoronto.ca
Summary
Research and development (R&D) spending by patentees indicates the health of Canada's innovative pharmaceutical and biotechnology sector. This R&D investment is crucial for meeting demand and navigating economic volatility.
Area of Science:
- Pharmaceutical Sciences
- Biotechnology
- Health Economics
Background:
- The global economy faces challenges, yet the pharmaceutical and biotechnology sectors show resilience.
- An aging population increases demand for novel therapeutic products.
- Company innovation, driven by R&D spending, is key to meeting this demand.
Purpose of the Study:
- To analyze the R&D expenditures of patentees in the Canadian pharmaceutical and biotechnology industry.
- To assess the sector's economic health and its capacity to meet market demands.
Main Methods:
- Utilizing annual reports from the Patented Medicine Prices Review Board (PMPRB) as primary data sources.
- Incorporating financial market data and the Therapeutic Directorate Annual Drug Submission Performance Report for comprehensive analysis.
Main Results:
- The Canadian innovative pharmaceutical and biotechnology sector demonstrates significant growth.
- Despite growth, the sector's output does not fully meet the demand for new therapeutics.
- The industry exhibits resilience, capable of withstanding economic fluctuations.
Conclusions:
- Patentees' R&D expenditure serves as a reliable indicator of industry health.
- This analysis provides insights into the Canadian sector's performance and its global standing.